Apicomplexan Parasites: Molecular Approaches toward Targeted Drug Development

— —

Katja Becker (University of Giessen, Germany) Paul M. Selzer (Intervet Innovation GmbH, Schwabenheim, Germany)

Apicomplexan Parasites

Molecular Approaches toward Targeted Drug Development

Katja Becker (University of Giessen, Germany), Paul M. Selzer (Intervet Innovation GmbH, Schwabenheim, Germany)

$350.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Blackwell Verlag GmbH
23 February 2011

Series: Drug Discovery in Infectious Diseases

This handbook is the first dealing with the discovery of drugs directed against apicomplexan parasites. Amongst others, this group of endoparasites includes the causative agents

of Malaria, Toxoplasmosis, and Babesiosis, the latter occurring mainly in animals. Written by renowned scientific experts from academia and industry, the book focuses on currentdrug development approaches for all apicomplexan diseases making it appealing to a large audience, ranging from research labs in academia to the human and veterinarian pharmaceutical industry. This work is the second volume of the new book series 'Drug Discovery in Infectious Diseases', edited by Prof. Dr Paul M. Selzer.

Edited by: Katja Becker (University of Giessen Germany)
Series edited by: Paul M. Selzer (Intervet Innovation GmbH Schwabenheim Germany)
Imprint: Blackwell Verlag GmbH
Country of Publication: Germany
Dimensions: Height: 246mm, Width: 178mm, Spine: 30mm
Weight: 1.148kg
ISBN: 9783527327317
ISBN 10: 3527327312
Series: Drug Discovery in Infectious Diseases
Pages: 550
Publication Date: 23 February 2011
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Volume editor: Prof. Dr. Katja Becker obtained her Academic Degree in Medicine at Heidelberg University. She carried out her doctoral-thesis as well as her Habilitation at the Biochemistry Centre, Heidelberg, before she obtained a Junior Group Leader Position at the Research Center for Infectious Diseases, Wurzburg University. Since 2000 she holds the Chair of Nutritional Biochemistry at the Justus-Liebig University Giessen. Scientifically she focuses on the characterization of redox active proteins as drug targets. She has produced more than 170 scientific publications and received numerous scientific awards including the Carus Medal of the German Academy of Sciences Leopoldina and the Leuckart Medal of the German Society for Parasitology. Since June 2009 she is a member of the Leopoldina. Series Editor: Prof. Dr. Paul M. Selzer studied Biology, Parasitology, and Biochemistry at the University of Tubingen, Germany, where he also received his PhD in Biochemistry. He spent three years in the parasitology and tropical disease laboratory of Prof. James H. McKerrow at the University of California, San Francisco (UCSF). During his professional career he worked as researcher and scientific manager for several pharmaceutical companies, being currently employed by Intervet Innovation GmbH, Germany, part of a leading Animal Health company. Dr. Selzer is also a visiting Professor and teacher in Biochemistry, Bioinformatics, and Chemoinformatics at the University of Tubingen, and holds an Honorary Professorship in the Department of Infection and Immunity at the University of Glasgow, UK.